Hepatic CMV-IE expression and distribution further defines the aetiological and prognostic subtypes of biliary atresia

Key Points

• Hepatic CMV-IE expression defines critical subtypes associated with biliary atresia outcomes.
• The study observed distinct distributions of CMV-IE expression across a cohort of biliary atresia cases.
• Analysis utilized registry records to highlight potential prognostic factors linked to biliary atresia subtypes.
• Findings emphasize the need for tailored treatment approaches based on specific hepatic expression patterns.